Nucleic Acid Testing Market to Garner Brimming Revenues by 2013 - 2019

Nucleic acid tests are performed in order to detect the presence of viral DNAs or RNAs in blood samples of patients. Three major processes involved in NAT are sample pooling and nucleic acid (NA) extraction, target NA amplification and target amplicon NA detection.Major NAT technologies include polymerase chain reaction (PCR), strand displacement amplification (SDA), ligase chain reaction (LCR), transcription-mediated amplification (TMA) and nucleic acid sequence based amplification (NASBA). Based on its major applications, NAT market can be classified into five major segments namely infectious diseases, genetic diseases, cancer, forensic testing and paternity testing.

Major growth drivers for the NAT market will include increasing prevalence of infectious diseases, cancer and genetic diseases, growing demand for technological advancements in testing methods, increasing end user acceptance and favorable regulatory mechanisms worldwide.

Request Report TOC @
https://www.transparencymarketresearch.com/nucleic-acid-testing.html

It was estimated that approximately one billion people suffered from various infectious diseases worldwide in 2012, which is one of the major segments of the NAT market, thus will affect this markets growth in future. Growing demand for new and improved testing methods that utilizes new reagent systems and automated amplification systems in wide range of applications will also provide this market a larger share in the coming future.

Geographically, North America dominated the global NAT market with the largest share in terms of revenue, followed by the European region. Asia-Pacific is expected to be the fastest growing market in the coming future because in most of its countries, the NAT market is currently at nascent stage or underpenetrated.

Request Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1834

This region is likely to evolve under the influence of increasing awareness regarding the testing methods and continuously improving economic condition. The major players operating in the NAT market are Abbott Laboratories, Inc., Becton, Dickinson and Company, Beckman Coulter, Inc.,Bio-Rad Laboratories, Inc., Illumina, Inc., Siemens Healthcare, Gen-Probe, Inc., bioMérieux SA, Novartis AG, F. Hoffmann-La Roche Ltd., Sequenom, Inc.and Tecan Group Ltd.

Pre Book Full Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=1834<ype=S

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. 

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

This release was published on openPR.